I am particularly worried about the risk to patients who obtain GLPs without direct and ongoing clinical supervision. Eimers team analyzed the health records of more than 42,000 adults taking at least two classes of antihypertensive medications who initiated semaglutide, tirzepatide or liraglutide
Thus, understanding these mechanisms provide novel potential for further drug development and treatment of RA
Novo is also awaiting FDA decision on an oral formulation of Wegovy, expected later this year
This product is not a medical drug, food item, cosmetic, or therapeutic agent
As the discontinuation rates were also high with the twice daily danuglipron at the phase 2 obesity trial (as discussed above), twice daily danuglirpon formulation will not advance into phase 3 studies, but an improved once-daily formulation with an aim to improve tolerability profile is currently under assessment [27]
San Diego